Coherus Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Coherus Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Coherus Biosciences Inc
Rating: 3.00758325
Author: Trendlyne DVM scores

about

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and o...

1.35 -0.02 (-1.46%)

44.44% Fall from 52W High

959.6K

XNAS Volume

XNAS 09 Sep, 2025 4:00 PM (EDT)

Board Meeting

The next board meeting for Coherus Biosciences Inc is on 10 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference See details

Not Eligible

Affordable Valuation

58.8 / 100

Technically Moderately Bullish

61.5 / 100

1Yr Price target upside is 236%

4 analysts

Coherus Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Coherus Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and o...

44.44% Fall from 52W High

SWOT Analysis

Coherus Biosciences Inc Live Price Chart